|
TWISTNB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.249600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.361400E-01 |
| Normal-vs-Stage2 |
9.425000E-01 |
| Normal-vs-Stage3 |
3.626600E-01 |
| Normal-vs-Stage4 |
3.302200E-01 |
| Stage1-vs-Stage2 |
8.288600E-01 |
| Stage1-vs-Stage3 |
2.767200E-01 |
| Stage1-vs-Stage4 |
1.903640E-01 |
| Stage2-vs-Stage3 |
5.133800E-01 |
| Stage2-vs-Stage4 |
5.522600E-01 |
| Stage3-vs-Stage4 |
9.265200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.418400E-01 |
| Normal-vs-AfricanAmerican |
8.195000E-01 |
| Normal-vs-Asian |
9.804000E-01 |
| Caucasian-vs-AfricanAmerican |
7.875600E-01 |
| Caucasian-vs-Asian |
9.692600E-01 |
| AfricanAmerican-vs-Asian |
9.536600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.896600E-01 |
| Normal-vs-Female |
5.436800E-01 |
| Male-vs-Female |
5.296200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.347200E-01 |
| Normal-vs-Extreme_Weight |
8.857400E-01 |
| Normal-vs-Obese |
9.998400E-01 |
| Normal-vs-Extreme_Obese |
6.639400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.826600E-01 |
| Normal_Weight-vs-Obese |
3.723000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.814600E-01 |
| Extreme_Weight-vs-Obese |
8.983000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.220400E-01 |
| Obese-vs-Extreme_Obese |
6.940600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.390600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.319000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.393800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.188000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.073000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.389850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.199800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.702500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.874020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.096200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.611800E-02 |
| Normal-VS-Type2 PRCC |
1.677650E-02 |
| Normal-VS-KIRP CIMP |
9.612200E-01 |
| Normal-VS-Unclassified PRCC |
8.921400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.845620E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.579800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.615800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.847800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.524000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.676600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.795700E-03 |
| Normal-vs-N1 |
9.903000E-01 |
| Normal-vs-N2 |
4.596100E-02 |
| N0-vs-N1 |
6.585900E-02 |
| N0-vs-N2 |
7.802400E-01 |
| N1-vs-N2 |
2.488800E-01 |
|
|
